dipyridamole has been researched along with fumaric acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borchert, HH; Gurny, R; Herrmann, W; Kramer, A; Lueckel, B; Ries, A; Siepe, S | 1 |
| Gurny, R; Kramer, A; Lueckel, B; Ries, A; Siepe, S | 1 |
| Inoue, R; Kawabata, Y; Onoue, S; Taniguchi, C; Wada, K; Yamada, S; Yamashita, K; Yamauchi, Y | 1 |
3 other study(ies) available for dipyridamole and fumaric acid
| Article | Year |
|---|---|
Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study.
Topics: Chemistry, Pharmaceutical; Citric Acid; Delayed-Action Preparations; Dipyridamole; Electron Spin Resonance Spectroscopy; Fumarates; Hydrogen-Ion Concentration; Hypromellose Derivatives; Methylcellulose; Polymers; Solubility; Succinic Acid; Tablets; Viscosity; Water | 2006 |
Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound.
Topics: Chemistry, Pharmaceutical; Dipyridamole; Fumarates; Hydrogen-Ion Concentration; Hypromellose Derivatives; Methylcellulose; Molecular Weight; Solubility; Succinic Acid; Tablets | 2008 |
Improved dissolution and pharmacokinetic behavior of dipyridamole formulation with microenvironmental pH-modifier under hypochlorhydria.
Topics: Achlorhydria; Administration, Oral; Animals; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Chromatography, Liquid; Crystallization; Crystallography, X-Ray; Dipyridamole; Disease Models, Animal; Drug Compounding; Drug Stability; Fumarates; Half-Life; Hydrogen-Ion Concentration; Male; Metabolic Clearance Rate; Microscopy, Electron, Scanning; Omeprazole; Phosphodiesterase Inhibitors; Powder Diffraction; Rats; Rats, Sprague-Dawley; Solubility; Spectrometry, Mass, Electrospray Ionization; Technology, Pharmaceutical | 2012 |